bromodeoxyuridine has been researched along with chalcone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujitsuka, H; Hara, A; Makita, H; Mori, H; Satoh, K; Tanaka, T; Tatematsu, N | 1 |
| Kang, HC; Kim, YC; Lee, SH; Park, EJ; Sohn, DH; Woo, SW; Zhao, YZ | 1 |
2 other study(ies) available for bromodeoxyuridine and chalcone
| Article | Year |
|---|---|
Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone, and quercetin.
Topics: 4-Nitroquinoline-1-oxide; Animals; Anticarcinogenic Agents; Biogenic Polyamines; Body Weight; Bromodeoxyuridine; Chalcone; Chalcones; Male; Mouth Neoplasms; Precancerous Conditions; Quercetin; Rats; Rats, Inbred F344 | 1996 |
Butein suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture.
Topics: Actins; Animals; Antimetabolites; Blotting, Western; Bromodeoxyuridine; Cell Differentiation; Cell Survival; Cells, Cultured; Chalcone; Chalcones; Collagen; Collagenases; DNA; Fibroblasts; Liver; Male; Matrix Metalloproteinase 13; Phosphodiesterase Inhibitors; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-1 | 2003 |